Commentary: Don’t let Adderall scarcity trigger a repeat of the opioid epidemic

Pharmacies in the U.S. are critically low on Adderall and its generic equivalents, leaving more than 26 million patients scrambling and competing for the pills since late summer. The scarcity is going to last for many more months because of supply chain problems as well as federal restrictions on manufacturers and imports.